Low-level (PPB) determination of cisplatin in cleaning validation (rinse water) samples. I. An atomic absorption spectrophotometric method

Drug Development and Industrial Pharmacy

Volumn 26, Issue 4, 2000, Pages 423-428

  Raghavan, Rajagopalan ^a   Mulligan, Jo Anne ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETONITRILE; CISPLATIN; DICHLOROMETHANE; DIETHYLDITHIOCARBAMIC ACID; PLATINUM; SODIUM; WATER;

ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; DRUG DETERMINATION; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; CISPLATIN; DETERGENTS; EQUIPMENT CONTAMINATION; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ATOMIC; WATER;

EID: 0034073239     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101249     Document Type: Article

References (28)

1. B. Rosenberg, in Cisplatin, Current Status and New Developments (A. W. Prestatko, S. T. Crooke, and S. K. Carter, Eds.), Academic, New York, 1980, pp. 9-20.
2. R. F. Ozols, B. J. Corden, J. Jacob, M. N. Wesley, Y. Ostchega, and R. C. Young, Ann. Intern. Med., 100, 19 (1984).
3. S. D. Williams and L. H. Einhorn, in Medical Oncology (P. Calabresi, P. S. Schein, and S. A. Rosenberg, Eds.), Macmillan, New York, 1985, pp. 1077-1088.
4. L.H. Einhorn, Eur. J. CancerClin. Oncol., 22 1289 (1986).
5. J. R. Durrant and G. A. Omura, in Medical Oncology (P. Calabresi, P. S. Schein, and S. A. Rosenberg, Eds.), Macmillan, New York, 1985, pp. 1004-1044.
6. B. S. Pearson and D. Raghavan, Br. J. Urol., 57, 690 (1985).
7. National Institutes of Health, Recommendations for Safe Handling of Parenteral Antineoplastic Drugs, NIH Publication No. 83-2621, U.S. Government Printing Office, Washington, DC.
8. Council on Scientific Affairs, AMA Council report: guidelines for handling parenteral antineoplastics, JAMA, 253(11), 1590 (1985).
9. National Study Commission on Cytotoxic Exposure, Recommendations for Handling of Cytotoxic Agents. Available from Louis P. Jeffrey, ScD. Chairman, National Study Commission on Cytotoxic Exposure, Massachusetts College of Pharmacy and Allied Health Sciences, 179 Longwood Avenue, Boston, MA 02115.
10. Clinical Oncological Society of Australia, Guidelines and recommendations for safe handling of antineoplastic agents, Med. J. Australia, 426-428 (1983).
11. R. B. Jones, R. Frank, and T. Mass, CA Cancer J. Clin., 33(5), 258 (1983).
12. Office of Occupational Medicine, Directorate of Technical Support, Occupational Safely and Health Administration, U.S. Department of Labor, OSHA work-practice guidelines for personnel dealing with cytotoxic drugs, Am. J. Hosp. Pharm., 43, 1193 (1986).
13. American Society of Hospital Pharmacists Clinical Affairs Department, ASHP technical assistance bulletin on handling cytotoxic drugs, Am. J. Hosp. Pharm., 47, 1033 (1990).
14. U.S. FDA Division of Field Investigations, Guide to Inspections of Validation of Cleaning Processes, FDA, Rockville, Maryland, July 1993.
15. H. L. Avallone, Pharm. Eng., 9, 37, 57 (1989).
16. S. W. Harder, Pharm. Technol., 8, 29 (1984).
17. D. W. Mendenhall, Drug Dev. Ind. Pharm., 15, 2105 (1989).
18. G. L. Fourman and M. W. Mullen, Pharm. Technol., 17, 54 (1993).
19. B. T. Callan, Pharm. Eng., 14, 56 (1994).
20. J. A. Shea, W. F. Shamrock, C. A. Abboud, R. W. Woodeshick, L. S. Nguyen, J. T. Rubino, and J. Segretario, Pharm. Dev. Technol., 1(1), 69 (1996).
21. J. M. Smith, Pharm. Technol., 17, 88 (1993).
22. B. Flickinger, Pharm. Cosmetic Qual., 1, 18 (1997).
23. C. M. Riley, J. Pharm. Biomed. Anal., 6, 669 (1988).
24. W. A. J. De Waal, F. J. M. J. Maessen, and J. C. Kraak, J. Pharm. Biomed. Anal., 8, 1 (1990).
25. A. Alimonti, F. Petrucci, C. Dominici, and S. Caroli., J. Trace Elem. Electrolytes Health Dis., 1, 79 (1987).
26. L. Charney and A. Forster, 28th Rocky Mountain Conf., Symp. Inductively Coupled Plasma Mass Spectrometry, Denver. Colorado, abstr. 185 (1986).
27. R. F. Borch, J. H. Markovitz, and M. E. Pleasants, Anal. Lett., 12, 917 (1979).
28. M. L. Denniston, L. A. Sternson, and A. J. Repta, Anal. Lett., 14, 451 (1981).